Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models.

Saved in:
Bibliographic Details
Title: Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models.
Authors: Han X; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center., Mei Y; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center., Mishra RK; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine., Bi H; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center., Jain AD; Department of Chemistry, and., Schiltz GE; Robert H. Lurie Comprehensive Cancer Center.; Department of Chemistry, and.; Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Zhao B; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center., Sukhanova M; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center., Wang P; Department of Pathology, Feinberg School of Medicine., Grigorescu AA; Department of Molecular Biosciences, Weinberg College of Arts & Sciences, Northwestern University, Evanston, Illinois, USA., Weber PC; Harrington Discovery Institute, Cleveland, Ohio, USA., Piwinski JJ; Harrington Discovery Institute, Cleveland, Ohio, USA., Prado MA; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Paulo JA; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA., Stephens L; Signaling Programme, The Babraham Institute, Cambridge, United Kingdom., Anderson KE; Signaling Programme, The Babraham Institute, Cambridge, United Kingdom., Abrams CS; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Yang J; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center., Ji P; Department of Pathology, Feinberg School of Medicine.; Robert H. Lurie Comprehensive Cancer Center.
Source: The Journal of clinical investigation [J Clin Invest] 2023 Mar 15; Vol. 133 (6). Date of Electronic Publication: 2023 Mar 15.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first